Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C C Nimmon

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
British Journal of Cancer|July 1, 1982
Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodiesA A Epenetos, C C Nimmon, J Arklie, et al.
Nuclear Medicine Communications|December 1, 1994
A prospective study comparing SPET with MRI and CT as prognostic indicators following severe closed head injuryS Bavetta, C C Nimmon, J White, et al.
British Journal of Urology|March 1, 1996
Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351M R Feneley, V U Chengazi, R S Kirby, et al.
Cancer Detection and Prevention|January 1, 1984
Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodiesA A Epenetos, J Shepherd, K E Britton, et al.
Nuclear Medicine Communications|August 1, 1984
Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findingsM Granowska, J Shepherd, K E Britton, et al.
Cancer|March 1, 1985
123I radioiodinated antibody imaging of occult ovarian cancerA A Epenetos, J Shepherd, K E Britton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1997
Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351)V U Chengazi, M R Feneley, D Ellison, et al.
Lancet (London, England)|November 6, 1982
Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumoursA A Epenetos, K E Britton, S Mather, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
British Journal of Cancer|July 1, 1982
Detection of human cancer in an animal model using radio-labelled tumour-associated monoclonal antibodiesA A Epenetos, C C Nimmon, J Arklie, et al.
Nuclear Medicine Communications|December 1, 1994
A prospective study comparing SPET with MRI and CT as prognostic indicators following severe closed head injuryS Bavetta, C C Nimmon, J White, et al.
British Journal of Urology|March 1, 1996
Prostatic radioimmunoscintigraphy: preliminary results using technetium-labelled monoclonal antibody, CYT-351M R Feneley, V U Chengazi, R S Kirby, et al.
Cancer Detection and Prevention|January 1, 1984
Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodiesA A Epenetos, J Shepherd, K E Britton, et al.
Nuclear Medicine Communications|August 1, 1984
Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findingsM Granowska, J Shepherd, K E Britton, et al.
Cancer|March 1, 1985
123I radioiodinated antibody imaging of occult ovarian cancerA A Epenetos, J Shepherd, K E Britton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1997
Imaging prostate cancer with technetium-99m-7E11-C5.3 (CYT-351)V U Chengazi, M R Feneley, D Ellison, et al.
Lancet (London, England)|November 6, 1982
Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumoursA A Epenetos, K E Britton, S Mather, et al.
Pageof 5